Olivier Taelman
Fortune : 37 634 $ au 31/05/2026
Fortune : 37 634 $ au 31/05/2026
Olivier Taelman currently works at Nyxoah SA, as Chief Executive Officer & Executive Director from 2020.
Mr. Taelman also formerly worked at Nevro Corp., as Business Director-Neuromodulation from 2013 to 2015 and Autonomic Technologies, Inc., as Vice President-Europe from 2015 to 2019.
Mr. Taelman received his undergraduate degree from Hasselt University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NYXOAH SA 0,03 % | 01/03/2026 | 12 500 ( 0,03 % ) | 37 634 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NYXOAH SA | Directeur Général | 01/11/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Corporate Officer/Principal | 01/11/2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01/12/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Health Technology |
Hasselt University
Hasselt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevro Corp.
Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nyxoah SA
Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national